4/4/2024 | SP | New Issue: Scotia prices $1.25 million of trigger autocallable contingent yield notes on Dexcom
|
3/4/2024 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallables linked to DexCom
|
3/1/2024 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to DexCom
|
3/1/2024 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to DexCom
|
12/13/2023 | SP | New Issue: Citi prices $2.5 million callable contingent coupon equity notes on DexCom
|
12/12/2023 | SP | New Issue: RBC prices $889,000 notes linked to 22 Raymond James securities selections
|
12/11/2023 | SP | New Issue: RBC prices $470,000 notes linked to 22 Raymond James securities selections
|
12/7/2023 | SP | New Issue: Citigroup prices $1.29 million contingent coupon equity linked autocalls on Dexcom
|
10/26/2023 | CV | Market Commentary: Convertibles trading ‘anemic’; Enovis active; DexCom lower; Anywhere Real Estate up
|
10/18/2023 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to DexCom
|
10/17/2023 | CV | Market Commentary: High-grade convertible notes in demand; DexCom rebounds; Rivian hits new outright high
|
10/13/2023 | CV | Market Commentary: DexCom, Insulet convertible notes active, level off after sell-off; PagerDuty below par
|
10/13/2023 | CV | Market Commentary: Morning Commentary: DexCom, Insulet convertible notes active, level off after sell-off
|
9/7/2023 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to DexCom
|
8/30/2023 | CV | Market Commentary: Insulet convertible notes in focus; DexCom gains; Wayfair active in secondary market
|
8/25/2023 | CV | Market Commentary: Affirm convertibles gain on earnings; DexCom notes hit new low; Fluor up outright
|
8/25/2023 | CV | Market Commentary: Morning Commentary: Secondary quiet as markets digest Fed speech; DexCom trades lower
|
8/22/2023 | SP | New Issue: BMO prices $600,000 barrier notes linked to Dexcom
|
8/16/2023 | SP | New Issue: RBC sells $750,000 issuer callable contingent coupon barrier notes tied to Dexcom
|
6/27/2023 | SP | New Issue: JPMorgan prices $1.55 million callable contingent interest notes linked to DexCom
|
6/13/2023 | SP | New Issue: JPMorgan prices $1.4 million callable contingent interest notes linked to DexCom
|
6/1/2023 | SP | New Issue: RBC prices $487,000 notes linked to basket of 20 Raymond James stock picks
|
6/1/2023 | SP | New Issue: RBC prices $1.56 million notes linked to basket of 20 Raymond James stock picks
|
5/10/2023 | SP | New Issue: Citigroup prices $772,000 10.63% autocallable equity-linked notes on Dexcom
|
5/5/2023 | CV | DexCom greenshoe increases 0.375% convertibles to $1.25 billion
|
5/3/2023 | CV | Market Commentary: Zynex on tap; DexCom convertibles in focus, jump on debut; CMS, FirstEnergy gain
|
5/3/2023 | CV | Market Commentary: Morning Commentary: DexCom convertibles in focus, jump on debut; CMS, FirstEnergy gain
|
5/3/2023 | CV | New Issue: DexCom prices upsized $1.1 billion five-year convertibles to yield 0.375%, up 37.5%
|
5/2/2023 | CV | Market Commentary: DexCom upsizes convertibles offering; CMS, FirstEnergy strong on debut; Chegg craters
|
5/2/2023 | CV | Market Commentary: Morning Commentary: DexCom convertibles on deck; CMS, FirstEnergy strong on debut
|
5/2/2023 | CV | DexCom talks $1 billion five-year convertibles to yield 0.25%-0.5%, up 37.5%-42.5%
|
4/17/2023 | SP | New Issue: JPMorgan sells $696,000 9% autocallable yield notes tied to DexCom, ServiceNow, Uber
|
4/11/2023 | SP | New Issue: JPMorgan prices $1.1 million 13.1% yield notes linked to two stocks, SPDR ETF
|
2/16/2023 | SP | New Issue: GS Finance prices $3.05 million callable contingent coupon equity notes on DexCom
|
12/5/2022 | SP | New Issue: HSBC sells $1.1 million autocallable contingent income barrier notes on DexCom
|
10/21/2022 | SP | New Issue: JPMorgan prices $784,000 17.65% autocallable contingent interest notes on three stocks
|
10/7/2022 | CV | Market Commentary: Semtech’s new convertibles fall along with broader semiconductor market; tech names off
|
10/7/2022 | CV | Market Commentary: Morning Commentary: Semtech upsizes convertibles; DexCom higher; Twitter still in play
|
8/11/2022 | SP | New Issue: UBS sells $883,000 8.9% airbag autocallable yield notes on DexCom
|
7/29/2022 | CV | Market Commentary: Enphase convertible notes improve; DexCom declines; Akamai active; Avaya in trouble
|
7/29/2022 | CV | Market Commentary: Morning Commentary: Enphase convertible notes continue to gain; DexCom declines
|
4/29/2022 | SP | New Issue: GS Finance sells $9.25 million basket-linked notes tied to 77 stocks
|
2/8/2022 | SP | New Issue: Citi sells $1.27 million autocallable phoenix securities on Dexcom
|
1/14/2022 | SP | New Issue: UBS prices $334,542 9.17% trigger yield optimization notes on DexCom
|
1/7/2022 | SP | New Issue: UBS sells $883,000 8.9% airbag autocallable yield notes on DexCom
|
12/6/2021 | SP | New Issue: BofA sells $2 million contingent income autocalls on DexCom and Tandem
|
11/29/2021 | SP | New Issue: UBS prices $1.49 million trigger phoenix autocallables linked to DexCom
|
11/22/2021 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to DexCom
|
11/12/2021 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to DexCom
|
11/12/2021 | SP | New Issue: UBS prices $1.1 million trigger phoenix autocallables linked to DexCom
|
10/25/2021 | SP | New Issue: UBS prices $2 million trigger phoenix autocallables linked to DexCom
|
8/26/2021 | SP | New Issue: GS Finance prices $13.14 million leveraged basket-linked notes on 179 stocks
|
8/2/2021 | SP | New Issue: RBC prices $4.58 million trigger autocallable contingent yield notes on ten stock basket
|
8/2/2021 | SP | New Issue: RBC prices $528,500 trigger autocallable contingent yield notes on basket of ten stocks
|
7/30/2021 | SP | New Issue: HSBC sells $5.07 million contingent income barrier autocalls with memory on tech stocks
|
7/23/2021 | SP | New Issue: RBC sells $1.23 million capped trigger gears on basket of ten stocks
|
7/22/2021 | SP | New Issue: UBS sells $9.6 million capped trigger gears on basket of 10 stocks
|
7/7/2021 | SP | New Issue: Citi prices $3.63 million callable contingent coupon equity notes on Dexcom
|
7/1/2021 | SP | New Issue: UBS sells $14.98 million capped trigger gears on basket of 10 stocks
|
6/18/2021 | CV | Market Commentary: Algonquin Power units flat outright, contract dollar-neutral; large seller in market
|
4/21/2021 | SP | New Issue: Citi sells $315,000 autocallable contingent coupon equity notes on three stocks
|
2/17/2021 | SP | New Issue: Credit Suisse sells $711,000 contingent coupon autocallable reverse converts on stocks
|
1/12/2021 | SP | New Issue: JPMorgan prices $1.05 million contingent interest autocallables linked to DexCom
|
12/29/2020 | SP | New Issue: GS Finance sells $1.71 million leveraged basket-linked notes on 23 stocks
|
12/23/2020 | CV | Market Commentary: DISH convertibles rebound; Palo Alto, Pioneer Natural Resources gain in active trading
|
12/23/2020 | CV | Market Commentary: Morning Commentary: Convertibles secondary market quiet; DexCom notes active early
|
10/28/2020 | CV | Market Commentary: Arch Resources convertibles on tap; Akamai, DexCom down after earnings beat expectations
|
10/20/2020 | SP | New Issue: UBS prices $1.1 million trigger autocallable contingent yield notes on two stocks
|
5/12/2020 | CV | Market Commentary: Convertibles primary set to price $2.05 billion in five deals; new notes flood secondary
|
5/12/2020 | CV | New Issue: DexCom prices upsized $1.05 billion 5.5-year convertibles to yield 0.25%, up 42.5%
|
5/11/2020 | CV | Market Commentary: Convertibles primary to price $3.8 billion of notes in five deals; pricing ‘aggressive’
|
5/11/2020 | CVLM | DexCom to buy back up to $260 million 0.75% convertibles due 2022
|
5/11/2020 | CV | Market Commentary: Morning Commentary: Convertibles primary to price $3.6 billion of notes over five deals
|
5/11/2020 | CV | DexCom talks $850 million convertibles due November 2025 to yield 0.125%-0.625%, up 40%-45%
|
2/14/2020 | CV | Market Commentary: SSR Mining convertible notes in focus on call news; Wayfair active; Dexcom, Insulet gain
|
1/28/2020 | SP | New Issue: JPMorgan prices $3.21 million contingent interest autocalls on Dexcom
|
1/23/2020 | SP | JPMorgan plans contingent interest autocalls on Dexcom
|
12/4/2019 | SP | New Issue: Citigroup prices $943,000 contingent coupon autocallables linked to DexCom, Apple
|
11/15/2019 | SP | New Issue: RBC prices $240,000 phoenix autocallable notes with memory coupon on DexCom
|
11/6/2019 | SP | RBC eyes phoenix autocallable notes with memory coupon on DexCom
|
8/19/2019 | CV | Market Commentary: Convertibles see pockets of improvement on swap; volumes light; recent issuance eyed
|
6/10/2019 | CV | Market Commentary: Calendar balloons; Dominion Energy, Vonage, Zynga on tap; Coupa Software gains continue
|
5/31/2019 | SP | Goldman amends Cusip for notes tied to basket of Russell 3000 stocks
|
5/9/2019 | SP | New Issue: Goldman sells $1 million notes tied to basket of Russell 3000 stocks
|
4/11/2019 | CV | Market Commentary: PAR Technology convertible notes expand; Intercept down outright, up on hedge; biotechs active
|
3/19/2019 | CV | Market Commentary: Euronet Worldwide convertibles in focus; DexCom notes active; Dermira gains continue
|
3/19/2019 | CV | Market Commentary: Morning Commentary: Euronet Worldwide convertibles in focus; DexCom notes active
|
1/7/2019 | CV | Market Commentary: Convertibles secondary tone improves; Ares Capital dominates trading; biotechs strong
|
12/21/2018 | BK | DexCom restates $200 million five-year revolving credit facility
|
12/3/2018 | CV | Market Commentary: Tesaro convertibles active, up on buyout by GlaxoSmithKline; iQIYI, Liberty Media gain
|
12/3/2018 | CV | DexCom greenshoe exercised, lifts 0.75% convertibles to $850 million
|
11/29/2018 | CV | Market Commentary: iQIYI offering upsized, looks cheap; DexCom, Liberty Media expand; Ensco notes active
|
11/28/2018 | CV | Market Commentary: iQIYI notes on tap; DexCom, Electronics for Imaging, Liberty Media sell $1.24 billion
|
11/28/2018 | CV | Market Commentary: Morning Commentary: DexCom, Electronics for Imaging, Liberty Media sell $1.24 billion
|
11/28/2018 | CV | New Issue: DexCom sells $750 million five-year convertible notes to yield 0.75%, up 32.5%
|
11/27/2018 | CV | Market Commentary: Convertibles market eyes DexCom, Electronics for Imaging, Liberty Media offerings
|
11/27/2018 | CV | Market Commentary: Morning Commentary: Market eyes DexCom, Electronics for Imaging, Liberty Media offerings
|
11/26/2018 | CV | Market Commentary: Convertibles calendar balloons; DexCom, Liberty Media, Electronics for Imaging on tap
|
11/26/2018 | CV | DexCom talks $750 million five-year convertible notes to yield 0.25%-0.75%, up 32.5%-37.5%
|
5/3/2018 | CV | Market Commentary: Convertibles market weighs Five9, Teladoc offerings with mixed views; NXP, Dexcom active
|
9/28/2017 | CV | Market Commentary: Western Asset prices cheap; DexCom steals the show as convertibles drop; PTC in focus
|
9/28/2017 | CV | Market Commentary: Morning Commentary: Western Asset prices cheap; DexCom steals the show as convertibles drop
|
6/12/2017 | CV | DexCom greenshoe lifts five-year 0.75% convertibles to $400 million
|
5/12/2017 | CV | Market Commentary: Stanley Black & Decker notches strong debut; Dermira deal touted; Becton Dickinson does well
|
5/11/2017 | CV | Market Commentary: Primary sees deal flow of $3.15 billion; Becton prices; Dermira rises; Black & Decker on tap
|
5/9/2017 | CV | Market Commentary: New deals from DexCom, Kaman active post-pricing; Dermira adds to calendar; Becton on tap
|
5/9/2017 | CV | Market Commentary: Morning Commentary: New issues from DexCom, Kaman climb above par in active trading
|
5/8/2017 | CV | New Issue: DexCom sells upsized $350 million five-year 0.75% convertibles, up 35%
|
5/8/2017 | CV | Market Commentary: DexCom, Kaman, Becton Dickinson enter market; Horizon falters as guidance lowered; Cobalt up
|
5/8/2017 | BK | DexCom to repay $75 million of facility debt with convertible proceeds
|
5/8/2017 | CV | Market Commentary: Morning Commentary: DexCom, Kaman, Becton Dickinson plan to tap market; Horizon falters
|
5/8/2017 | CV | DexCom selling $300 million five-year convertible notes to yield 0.75%-1.25%, up 30%-35%
|
3/6/2017 | BK | DexCom draws $75 million revolving loan at 3.19% for six months
|
6/20/2016 | BK | DexCom enters into $200 million five-year revolving credit agreement
|
9/20/2010 | PP | DexCom converts all $6 million 4.75% convertibles due 2027 into stock
|
6/11/2010 | CVLM | DexCom opts to redeem $1.5 million of 4.75% convertible notes due 2027
|
3/15/2010 | CV | DexCom plans to swap shares for $18 million in 4.75% convertible notes
|
3/11/2010 | CV | DexCom to issue common shares for $11.15 million 4.75% convertibles
|
2/24/2010 | CV | DexCom issues shares in exchange for $9.75 million 4.75% convertibles
|
2/1/2010 | CV | DexCom issues shares in exchange for $9.1 million 4.75% convertibles
|
11/4/2009 | CVHY | DexCom files $100 million shelf covering preferreds, stock and debt
|
2/12/2009 | SS | Wells Fargo reports 6.02% stake in DexCom
|
3/7/2007 | CV | DexCom greenshoe exercised, lifting convertibles to $60 million
|
3/6/2007 | CV | New Issue: DexCom prices $40 million 20-year convertibles at 4.75%, up 20%
|
3/6/2007 | CV | Market Commentary: Bausch & Lomb gains; DexCom quiet on debut; Barnes absent in gray; Cypress, Developers launch deals
|
8/18/2006 | BT | DexCom wins stay in Abbott patent case
|
8/18/2006 | BT | Market Commentary: Natus stock up 5.6% on $26.75 million stock sale; DexCom gets stay in Abbott patent infringement suit
|
4/27/2006 | BT | New Issue: DexCom raises $33.6 million in spot follow-on of 1.4 million shares at $24 each
|
3/29/2006 | BT | DexCom, Abbott patent lawsuit gets new review by trademark office
|
3/27/2006 | BT | DexCom gets FDA approval for blood-sugar monitoring system
|